The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Orafluke 5 % w/v Oral Suspension

Interchem Ireland LtdVPA10555/003/001

Main Information

Trade NameOrafluke 5 % w/v Oral Suspension
Active SubstancesFenbendazole
Dosage FormOral suspension
Licence HolderInterchem Ireland Ltd
Licence NumberVPA10555/003/001

Group Information

ATC CodeQP52AC13 fenbendazole
QP52AG05 rafoxanide
Therapeutic ClassEndoparasiticide


License statusAuthorised
Licence Issued18/04/2008
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back